Logo image of AKUS

AKOUOS INC (AKUS) Stock News

NASDAQ:AKUS - Nasdaq - US00973J1016 - Common Stock - Currency: USD

13.29  +0.14 (+1.06%)

After market: 13.75 +0.46 (+3.46%)

AKUS Latest News, Press Relases and Analysis

News Image
2 years ago - Benzinga

Around $375 Million Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying

Although US stocks closed mixed on Thursday, there were a few notable insider trades.

Mentions: LYV GOCO IE

News Image
2 years ago - Eli Lilly and Company

Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Akouos, Inc. (NASDAQ: AKUS). The acquisition...

Mentions: LLY

News Image
2 years ago - Eli Lilly and Company

Lilly and Akouos Announce Expiration of Akouos Tender Offer

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced that the tender offer to purchase all of the issued and...

Mentions: LLY

News Image
3 years ago - Weiss Law

SHAREHOLDER ALERT: Weiss Law Investigates Akouos, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Akouos, Inc. ("Akouos"...

Mentions: LLY

News Image
3 years ago - InvestorPlace

Why Is Akouos (AKUS) Stock Up 85% Today?

As a pharmaceutical giant seeks to delve deeper into gene therapy, today's merger announcement has AKUS stock traders in a frenzy.

Mentions: LLY

News Image
3 years ago - Benzinga

Health Care Company Eli Lilly Announces Acquisition of Akouos

Eli Lilly (NYSE:LLY) has announced an acquisition of Akouos (NASDAQ:AKUS) that is expected to be completed in Q4 of 2022.

Mentions: LLY

News Image
2 years ago - Seeking Alpha

Akouos GAAP EPS of -$0.54 beats by $0.11 (NASDAQ:AKUS)

Akouos press release (AKUS): Q3 GAAP EPS of -$0.54 beats by $0.11.Cash, cash equivalents, and marketable securities were $169.3 million

News Image
2 years ago - Akouos, Inc.

Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights

-Received clearance from FDA for the AK-OTOF IND application to initiate a Phase 1/2, first in human, pediatric clinical trial -Continued progress...

News Image
3 years ago - The Motley Fool

Why Akouos Stock Is on Fire Today

A buyout agreement is lighting a fire underneath the biotech's shares today.

Mentions: LLY

News Image
3 years ago - InvestorPlace

Zovio (ZVO) Stock Soars 90% Ahead of Oct. 25 Dissolution Vote

Zovio (ZVO) stock is rocketing higher on Tuesday as investors prepare for an incredibly important vote next week!

Mentions: ZVO RMED AVEO

News Image
3 years ago - Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Akouos, Inc. has obtained a Fair Price in its transaction with Eli Lilly

/PRNewswire/ -- Ademi LLP is investigating Akouos (NASDAQ: AKUS) for possible breaches of fiduciary duty and other violations of law in its transaction with...

News Image
3 years ago - Eli Lilly and Company

Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced a definitive agreement for Lilly to acquire Akouos, a...

Mentions: LLY